Successful Treatment with Dupilumab in a Patient with Severe, Difficult to Treat Atopic Dermatitis: Beware of Symptomatic Adrenal Insufficiency due to Abrupt Discontinuation of Potent Topical Corticosteroids

MeSH terms

• Administration, Cutaneous
• Adrenal Cortex Hormones / administration & dosage
• Adrenal Cortex Hormones / adverse effects*
• Adrenal Insufficiency / blood
• Adrenal Insufficiency / chemically induced*
• Adrenal Insufficiency / diagnosis
• Adrenal Insufficiency / drug therapy
• Antibodies, Monoclonal / therapeutic use*
• Antibodies, Monoclonal, Humanized
• Betamethasone / administration & dosage
• Betamethasone / adverse effects
• Betamethasone / analogs & derivatives*
• Biomarkers / blood
• Dermatitis, Atopic / diagnosis
• Dermatitis, Atopic / drug therapy*
• Drug Substitution / adverse effects*
• Humans
• Hydrocortisone / administration & dosage
• Hydrocortisone / blood
• Male
• Middle Aged
• Remission Induction
• Severity of Illness Index
• Treatment Outcome